ebook img

Immunization and States: The Politics of Making Vaccines PDF

239 Pages·2021·15.767 MB·English
Save to my drive
Quick download
Download
Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.

Preview Immunization and States: The Politics of Making Vaccines

IMMUNIZATION AND STATES Globally, there has been a move away from national public sector vaccine devel- opment over the past 30 years. Immunization and States: The Politics of Making Vaccines explores vaccine geopolitics, analyzing why, and how this move hap- pened, before looking at the ramifications in the context of Covid-19. This unique book uses eight country studies – looking at Croatia, India, Iran, the Netherlands, Romania, Serbia, Spain, and Sweden – to explore the role of public sector vaccine institutes, past, and present. Raising questions about national sov- ereignty, the erosion of multilateralism, and geopolitics, it also contributes to debates around public interest and privatization in the health sector. An extended introduction sets the chapters in an international context, whilst the epilogue looks forward to the future of vaccine development and production. This is an important book for students, scholars, and practitioners with an interest in vaccine development from a range of fields, including public health, medicine, science and technology studies, history of medicine, politics, interna- tional relations, and the sociology of health and illness. Stuart Blume is Emeritus Professor in the Department of Anthropology, Uni- versity of Amsterdam, the Netherlands. Baptiste Baylac-Paouly is fixed-term Lecturer in History of Medicine at the Medical School Lyon-Est, France. IMMUNIZATION AND STATES The Politics of Making Vaccines Edited by Stuart Blume and Baptiste Baylac-Paouly First published 2022 by Routledge 2 Park Square, Milton Park, Abingdon, Oxon OX14 4RN and by Routledge 605 Third Avenue, New York, NY 10158 Routledge is an imprint of the Taylor & Francis Group, an informa business © 2022 selection and editorial matter, Stuart Blume and Baptiste Baylac-Paouly; individual chapters, the contributors The right of Stuart Blume and Baptiste Baylac-Paouly to be identified as the authors of the editorial material, and of the authors for their individual chapters, has been asserted in accordance with sections 77 and 78 of the Copyright, Designs and Patents Act 1988. All rights reserved. No part of this book may be reprinted or reproduced or utilised in any form or by any electronic, mechanical, or other means, now known or hereafter invented, including photocopying and recording, or in any information storage or retrieval system, without permission in writing from the publishers. Trademark notice: Product or corporate names may be trademarks or registered trademarks, and are used only for identification and explanation without intent to infringe. British Library Cataloguing-in-Publication Data A catalogue record for this book is available from the British Library Library of Congress Cataloging-in-Publication Data A catalog record has been requested for this book ISBN: 978-0-367-67226-3 (hbk) ISBN: 978-0-367-67227-0 (pbk) ISBN: 978-1-003-13034-5 (ebk) DOI: 10.4324/9781003130345 Typeset in Bembo by KnowledgeWorks Global Ltd. CONTENTS List of figures vii List of tables viii List of contributors ix Acknowledgements xii Introduction 1 Stuart Blume and Baptiste Baylac-Paouly 1 The privatization of societal vaccinology in the Netherlands 20 Jan Hendriks 2 The rise and fall of state vaccine institutions in Spain (1871−1986) 44 María-José Báguena and María-Isabel Porras 3 Politics of vaccination in Sweden: the National Bacteriological Laboratory SBL (1909–1993) and current debates 65 Motzi Eklöf 4 The failed promises of a brighter future: the Institute of Immunology in Zagreb from a public asset to a privatized burden 89 Vedran Duanˇci´c, Snježana Ivˇci´c, and Ana Vraˇcar vi Contents 5 Wilful neoliberal incapacitation of India’s public sector vaccine institutions 110 Madhavi Yennapu 6 Start with the world and continue in isolation: the Pasteur and Razi Institutes’ vaccine legacy in Iran 138 Payam Roshanfekr and Parisa Roshanfekr 7 Translating Pasteur’s vision in Eastern Europe: the role of the Cantacuzino Institute in Romanian vaccination policies and vaccine production 155 Valentin-Veron Toma 8 Vaccine production in Serbia: political and socio-cultural determinants in historical perspective 176 Vesna Trifunovi´c Epilogue: states and vaccines in the age of Covid-19 199 Stuart Blume and Maurizia Mezza Index 218 FIGURES 1.1 FAIR founders (from left to right): Hans Cohen, Charles Mérieux, and Jonas Salk (1984) 24 1.2 Vaccinology training courses for international capacity building since the 1970s. 25 1.3 Relative contribution of vaccines produced by the public sector for diseases addressed by the Netherlands Immunization Programme (NIP) between 1950 and 2020. 32 5.1 BCGVL Chennai: Production, purchase order from the government, and supply of vaccines to the UIP 126 5.2 Central Research Institute (CRI) Kasauli: Production, purchase order from the government, and supply of DT vaccines to the UIP 126 5.3 Central Research Institute (CRI) Kasauli: Production, purchase order from the government, and supply of TT vaccines to the UIP 127 5.4 Central Research Institute (CRI) Kasauli: Production, purchase order from the government, and supply of DPT vaccines to the UIP 127 5.5 Pasteur Institute of India (PII) Coonoor: Production, purchase order from the government, and supply of DPT vaccines to the UIP 128 5.6 Pasteur Institute of India (PII) Coonoor: Production, purchase order from the government, and supply of DT vaccines to the UIP 128 5.7 Pasteur Institute of India (PII) Coonoor: Production, purchase order from the government, and supply of TT vaccines to the UIP 129 TABLES 1.1 Milestones in the deconstruction of Dutch vaccinology 37 5.1 Vaccine R&D and production in Public Sector Vaccine Institutions (PSVIs) established since 1800 112 5.2 The difference in vaccine prices between the public sector (PSVIs) and private companies per dose (0.5 ml) 120 5.3 Percentage share of vaccine production by private and public sector in India 125 CONTRIBUTORS María-José Báguena passed away on 13 March 2021. She was at that time a full Professor of History of Science at the University of Valencia, as well as a member of the López Piñero Interuniversity Institute in Valencia. Her research was focused on the historical evolution of infectious diseases, the institutions and people who carried out microbiological research in Spain, and policies for the prevention and treatment of these diseases. Baptiste Baylac-Paouly is a fixed-term lecturer at the Medical School of Lyon-Est, University Lyon 1. His research interest is the history of infectious diseases control strategies and policies. After working for 5 years on meningitis A in Africa and Brazil, he is now working on polio control strategies and policies in France in the second half of the twentieth century. Stuart Blume is Emeritus Professor of Science & Technology Studies and a member of the Department of Anthropology at the University of Amsterdam. He has been an advisor on bioethics to the World Federation of the Deaf, a ‘Professor 2’ at the University of Oslo, and ‘Prometeo’ fellow at the University of Cuenca (Ecuador). Vedran Duancˇic´ holds a PhD in history and civilization from the European University Institute in Florence (2016). He specializes in the modern intellectual history and the twentieth-century history of science. Between 2017 and 2021, he was a postdoctoral researcher at the Institute for the History and Philosophy of Science at the Croatian Academy of Sciences and Arts in Zagreb. Motzi Eklöf is an associate professor in health and society. After 20 years in the academy, she is now working as independent researcher. Her research area is the social and cultural history of medicine and health, including ethical aspects.

See more

The list of books you might like

Most books are stored in the elastic cloud where traffic is expensive. For this reason, we have a limit on daily download.